Nicotine's oxidative and antioxidant properties in CNS

Life Sciences

Volumn 71, Issue 24, 2002, Pages 2807-2820

  Newman, Mary B ^a,b   Arendash, Gary W ^b   Shytle, R Douglas ^a,b   Bickford, Paula C ^a,c   Tighe, Thomas ^a,b   Sanberg, Paul R ^a,b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Antioxidant; Neurodegenerative; Nicotine; Nicotinic receptor; Oxidative stress; Pro oxidant

Indexed keywords

ANTIOXIDANT; IRON; NICOTINE; NICOTINIC RECEPTOR; REACTIVE OXYGEN METABOLITE; SCAVENGER;

AEROBIC METABOLISM; ANTIOXIDANT ACTIVITY; BEHAVIOR; BINDING AFFINITY; CENTRAL NERVOUS SYSTEM; DEGENERATIVE DISEASE; DRUG MECHANISM; EXTRACELLULAR SPACE; HUMAN; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PERIPHERAL NERVOUS SYSTEM; PHYSICAL DISEASE BY BODY FUNCTION; SHORT SURVEY;

EID: 0036836798     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(02)02135-5     Document Type: Review

References (78)

1. Church D.F., Pryor W.A. Free-radical chemistry of cigarette smoke and its toxicological implications. Environmental Health Perspectives. 64:1985;111-126.
2. Pryor W.A., Hales B.J., Premovic P.I., Church D.F. The radicals in cigarette tar: their nature and suggested physiological implications. Science. 220(4595):1983;425-427.
3. Pryor W.A., Prier D.G., Church D.F. Electron-spin resonance study of mainstream and sidestream cigarette smoke: nature of the free radicals in gas-phase smoke and in cigarette tar. Environmental Health Perspectives. 47:1983;345-355.
4. Halliwell B., Gutteridge J.M.C. Free radicals in medicine and biology. 1999;Oxford University Press, Oxford.
5. Newhouse P.A., Potter A., Levin E.D. Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Implications for therapeutics. Drugs Aging. 11(3):1997;206-228.
6. Karlin A., Akabas M.H. Toward a structural basis for the function of nicotinic acetylcholine receptors and their cousins. Neuron. 15(6):1995;1231-1244.
7. Le Novere N., Changeux J.P. Molecular evolution of the nicotinic acetylcholine receptor: an example of multigene family in excitable cells. Journal of Molecular Evolution. 40(2):1995;155-172.
8. Lindstrom J., Anand R., Gerzanich V., Peng X., Wang F., Wells G. Structure and function of neuronal nicotinic acetylcholine receptors. Progress in Brain Research. 109:1996;125-137.
9. Lukas R.J., Changeux J.P., Le Novere N., Albuquerque E.X., Balfour D.J., Berg D.K., Bertrand D., Chiappinelli V.A., Clarke P.B., Collins A.C., Dani J.A., Grady S.R., Kellar K.J., Lindstrom J.M., Marks M.J., Quik M., Taylor P.W., Wonnacott S. International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits. Pharmacological Review. 51(2):1999;397-401.
10. Albuquerque E.X., Pereira E.F., Castro N.G., Alkondon M., Reinhardt S., Schroder H., Maelicke A. Nicotinic receptor function in the mammalian central nervous system. Annals of the New York Academy of Sciences. 757:1995;48-72.
11. Gotti C., Fornasari D., Clementi F. Human neuronal nicotinic receptors. Progress in Neurobiology. 53(2):1997;199-237.
12. Lukas R.J., Bencherif M. Heterogeneity and regulation of nicotinic acetylcholine receptors. International Review of Neurobiology. 34:1992;25-131.
13. Papke R.L. The kinetic properties of neuronal nicotinic receptors: genetic basis of functional diversity. Progress in Neurobiology. 41(4):1993;509-531.
14. Paterson D., Nordberg A. Neuronal nicotinic receptors in the human brain. Progress in Neurobiology. 61(1):2000;75-111.
15. Ochoa E.L., Chattopadhyay A., McNamee M.G. Desensitization of the nicotinic acetylcholine receptor: molecular mechanisms and effect of modulators. Cellular and Molecular Neurobiology. 9(2):1989;141-178.
16. Hulihan-Giblin B.A., Lumpkin M.D., Kellar K.J. Effects of chronic administration of nicotine on prolactin release in the rat: inactivation of prolactin response by repeated injections of nicotine. Journal of Pharmacology and Experimental Therapeutics. 252(1):1990;21-25.
17. Sie H. Oxidative stressII. Oxidants and Antioxidants. 1991;Academic Press, London.
18. Yildiz D., Ercal N., Armstrong D.W. Nicotine enantiomers and oxidative stress. Toxicology. 130(2-3):1998;155-165.
19. Yildiz D., Liu Y.S., Ercal N., Armstrong D.W. Comparison of pure nicotine- and smokeless tobacco extract-induced toxicities and oxidative stress. Arch Environ Contam Toxicol. 37(4):1999;434-439.
20. Brazell M.P., Mitchell S.N., Joseph M.H., Gray J.A. Acute administration of nicotine increases the in vivo extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid and ascorbic acid preferentially in the nucleus accumbens of the rat: comparison with caudate-putamen. Neuropharmacology. 29(12):1990;1177-1185.
21. Benowitz N.L., Porchet H., Jacob P. III Pharmacokinetics, metabolism, and pharmacodynamics of nicotine. Stolerman I.P. Nicotine Psychopharmacology. 1990;112-157 Oxford University Press, Oxford.
22. Henningfield J.E., Stapleton J.M., Benowitz N.L., Grayson R.F., London E.D. Higher levels of nicotine in arterial blood than in venous blood after cigarette smoking. Drugs and Alcohol Dependence. 33(23-29):1993.
23. Ghosheh O.A., Dwoskin L.P., Miller D.K., Crooks P.A. Accumulation of nicotine and its metabolites in rat brain after intermittent or continuous peripheral administration of [2′-(14)C]nicotine. Drug Metabolism and Disposition. 29(5):2001;645-651.
24. Rowell P.P., Li M. Dose-response relationship for nicotine-induced up-regulation of rat brain nicotinic receptors. Journal of Neurochemistry. 68(5):1997;1982-1989.
25. Ashakumary L., Vijayammal P.L. Effect of nicotine on antioxidant defence mechanisms in rats fed a high-fat diet. Pharmacology. 52(3):1996;153-158.
26. Wetscher G.J., Bagchi M., Bagchi D., Perdikis G., Hinder P.R., Glaser K., Hinder R.A. Free radical production in nicotine treated pancreatic tissue. Free Radical Biology and Medicine. 18(5):1995;877-882.
27. Wetscher G.J., Bagchi D., Perdikis G., Bagchi M., Redmond E.J., Hinder P.R., Glaser K., Hinder R.A. In vitro free radical production in rat esophageal mucosa induced by nicotine. Digestive Diseases and Sciences. 40(4):1995;853-858.
28. Przyklenk K. Nicotine exacerbates postischemic contractile dysfunction of 'stunned' myocardium in the canine model. Possible role of free radicals. Circulation. 89(3):1994;1272-1281.
29. Ogle C.W., Qiu B.S., Cho C.H. Nicotine and gastric ulcers in stress. Journal of Physiology-Paris. 87(6):1993;359-365.
30. Kozlovskis-Wade P.L., Smets M.J., Myerburg R.J. The effect of nicotine on DNA repair in adult myocytes. Journal of Molecular and Cellular Cardiol. 30(8):1998;1483-1491.
31. Morens D.M., Grandinetti A., Reed D., White L.R., Ross G.W. Cigarette smoking and protection from Parkinson's disease: false association or etiologic clue? Neurology. 45(6):1995;1041-1051.
32. van Duijn C.M., Hofman A. Relation between nicotine intake and Alzheimer's disease. [see comments] Brittish Medical Journal. 302(6791):1991;1491-1494.
33. Lichtensteiger W., Hefti F., Felix D., Huwyler T., Melamed E., Schlumpf M. Stimulation of nigrostriatal dopamine neurones by nicotine. Neuropharmacology. 21(10):1982;963-968.
34. Ferger B., Kuschinsky K. Biochemical studies support the assumption that dopamine plays a minor role in the EEG effects of nicotine. Psychopharmacology (Berlin). 129(2):1997;192-196.
35. Imperato A., Mulas A., Di Chiara G. Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. Eurpean Journal of Pharmacology. 132(2-3):1986;337-338.
36. Fagerstrom K.O., Pomerleau O., Giordani B., Stelson F. Nicotine may relieve symptoms of Parkinson's disease. Psychopharmacology (Berlin). 116(1):1994;117-119.
37. Kelton M.C., Kahn H.J., Conrath C.L., Newhouse P.A. The effects of nicotine on Parkinson's disease. Brain and Cognition. 43(1-3):2000;274-282.
38. Newhouse P.A., Potter A., Kelton M., Corwin J. Nicotinic treatment of Alzheimer's disease. Biological Psychiatry. 49(3):2001;268-278.
39. Newhouse P.A., Sunderland T., Tariot P.N., Blumhardt C.L., Weingartner H., Mellow A., Murphy D.L. Intravenous nicotine in Alzheimer's disease: a pilot study. Psychopharmacology. 95(2):1988;171-175.
40. Sahakian B., Jones G., Levy R., Gray J., Warburton D. The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of the Alzheimer type. [see comments] British Journal of Psychiatry. 154:1989;797-800.
41. Decker M.W., Brioni J.D., Bannon A.W., Arneric S.P. Diversity of Neuronal nicotinic acetylcholine receptors: lessons from behavior and implications for CNS therapeutics. Life Sciences. 56(8):1995;545-570.
42. Prendergast M.A., Terry A.V. Jr., Jackson W.J., Marsh K.C., Decker M.W., Arneric S.P., Buccafusco J.J. Improvement in accuracy of delayed recall in aged and non-aged, mature monkeys after intramuscular or transdermal administration of the CNS nicotinic receptor agonist ABT-418. Psychopharmacologia. 130(3):1997;276-284.
43. Loeffler D.A., Connor J.R., Juneau P.L., Snyder B.S., Kanaley L., DeMaggio A.J., Nguyen H., Brickman C.M., LeWitt P.A. Transsferrin and iron in normal, Alzheirmer's Disease, and Parkinson's Disease brain regions. Journal of Neurochemistry. 65(2):1995;710-716.
44. Olanow C.W., Arendash G.W. Metals and free radicals in neurodegeneration. Current Opinions in Neurology. 7(6):1994;548-558.
45. Linert W., Bridge M.H., Huber M., Bjugstad K.B., Grossman S., Arendash G.W. In vitro and in vivo studies investigating possible antioxidant actions of nicotine: relevance to Parkinson's and Alzheimer's diseases. Biochimica Biophysica Acta. 1454(2):1999;143-152.
46. Ferger B., Spratt C., Earl C.D., Teismann P., Oertel W.H., Kuschinsky K. Effects of nicotine on hydroxyl free radical formation in vitro and on MPTP-induced neurotoxicity in vivo. Naunyn Schmiedeberg's Archives of Pharmacology. 358(3):1998;351-359.
47. Nordberg A., Hellstrom-Lindahl E., Lee M., Johnson M., Mousavi M., Hall R., Perry E., Bednar I., Court J. Chronic nicotine treatment reduces beta-amyloidosis in the brain of a mouse model of Alzheimer's disease (APPsw). Journal of Neurochemistry. 81(3):2002;655-658.
48. Bhagwat S.V., Vijayasarathy C., Raza H., Mullick J., Avadhani N.G. Preferential effects of nicotine and 4-(N-methyl-N-nitrosamine)-1-(3-pyridyl)-1-butanone on mitochondrial glutathione S-transferase A4-4 induction and increased oxidative stress in the rat brain. Biochemical Pharmacology. 56(7):1998;831-839.
49. Nordberg A., Winblad B. Reduced number of [3H]nicotine and [3H]acetylcholine binding sites in the frontal cortex of Alzheimer brains. Neuroscience Letters. 72(1):1986;115-119.
50. Perry E.K., Morris C.M., Court J.A., Cheng A., Fairbairn A.F., McKeith I.G., Irving D., Brown A., Perry R.H. Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology. Neuroscience. 64(2):1995;385-395.
51. Guan Z.Z., Miao H., Tian J.Y., Unger C., Nordberg A., Zhang X. Suppressed expression of nicotinic acetylcholine receptors by nanomolar beta-amyloid peptides in PC12 cells. Journal of Neural Transmission. 108(12):2001;1417-1433.
52. Guan Z., Zhang X., Nordberg A. Influence of lipid peroxidation on the nicotinic acetylcholine receptors in PC12 cells. Neuroscience Letters. 286(3):2000;163-166.
53. Rogers A.T., Wonnacott S. Differential upregulation of alpha 7 and alpha 3 subunit-containing nicotinic acetylcholine receptors in rat hippocampal and PC12 cell cultures. Biochemical Society Transactions. 25(3):1997;544S.
54. Guan Z.Z., Zhang X., Mousavi M., Tian J.Y., Unger C., Nordberg A. Reduced expression of neuronal nicotinic acetylcholine receptors during the early stages of damage by oxidative stress in PC12 cells. Journal of Neuroscience Research. 66(4):2001;551-558.
55. Meyer E.M., Tay E.T., Papke R.L., Meyers C., Huang G.L., de Fiebre C.M. 3-[2,4-Dimethoxybenzylidene]anabaseine (DMXB) selectively activates rat alpha7 receptors and improves memory-related behaviors in a mecamylamine-sensitive manner. Brain Research. 768(1-2):1997;49-56.
56. Meyer E.M., Tay E.T., Zoltewicz J.A., Meyers C., King M.A., Papke R.L., De Fiebre C.M. Neuroprotective and memory-related actions of novel alpha-7 nicotinic agents with different mixed agonist/antagonist properties. The Journal Pharmacology and Experimental Therapeutics. 284(3):1998;1026-1032.
57. Stevens K.E., Kem W.R., Mahnir V.M., Freedman R. Selective alpha7-nicotinic agonists normalize inhibition of auditory response in DBA mice. Psychopharmacology (Berl). 136(4):1998;320-327.
58. Adler L.E., Olincy A., Waldo M., Harris J.G., Griffith J., Stevens K., Flach K., Nagamoto H., Bickford P., Leonard S.et al. Schizophrenia, sensory gating, and nicotinic receptors. Schizophrenia Bulletin. 24(2):1998;189-202.
59. Liu Q., Kawai H., Berg D.K. beta-Amyloid peptide blocks the response of alpha 7-containing nicotinic receptors on hippocampal neurons. Proceedings of the National Academy of Sciences of the United States of America. 98(8):2001;4734-4739.
60. Kihara T., Shimohama S., Sawada H., Kimura J., Kume T., Kochiyama H., Maeda T., Akaike A. Nicotinic receptor stimulation protects neurons against beta-amyloid toxicity. Annals of Neurology. 42(2):1997;159-163.
61. Kihara T., Shimohama S., Sawada H., Honda K., Nakamizo T., Shibasaki H., Kume T., Akaike A. alpha 7 nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block A beta-amyloid-induced neurotoxicity. The Journal of Biological Chemistry. 276(17):2001;13541-13546.
62. Li Y., King M.A., Meyer E.M. alpha7 nicotinic receptor-mediated protection against ethanol-induced oxidative stress and cytotoxicity in PC12 cells. Brain Research. 861(1):2000;165-167.
63. Kitagawa H., Takenouchi T., Wesnes K., Kramer W., Clody D.E. Phase I studies of GTS-21 to assess the safety, tolerability, PK, and effects on measures of cognitive function in normal volunteers. 6th International Conference on Alzheimer's Diesease Abstract. vol. 765:1998.
64. Seguela P., Wadiche J., Dineley-Miller K., Dani J.A., Patrick J.W. Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium. Journal of Neuroscience. 13(2):1993;596-604.
65. Clarke P.B., Schwartz R.D., Paul S.M., Pert C.B., Pert A. Nicotinic binding in rat brain: autoradiographic comparison of [3H] acetylcholine, [3H]nicotine, and [125I]-alpha-bungarotoxin. Journal of Neuroscience. 5(5):1985;1307-1315.
66. Airaksinen M.S., Paetau A., Paljarvi L., Reinikainen K., Riekkinen P., Suomalainen R., Panula P. Histamine neurons in human hypothalamus: anatomy in normal and Alzheimer diseased brains. Neuroscience. 44(2):1991;465-481.
67. Nakamura S., Takemura M., Ohnishi K., Suenaga T., Nishimura M., Akiguchi I., Kimura J., Kimura T. Loss of large neurons and occurrence of neurofibrillary tangles in the tuberomammillary nucleus of patients with Alzheimer's disease. Neuroscience Letters. 151(2):1993;196-199.
68. Shytle R.D., Borlongan C.V., Sanberg P.R. Nicotine blocks kainic acid-induced wet dog shakes in rats. Neuropsychopharmacology. 13(3):1995;261-264.
69. Maggio R., Riva M., Vaglini F., Fornai F., Molteni R., Armogida M., Racagni G., Corsini G.U. Nicotine prevents experimental parkinsonism in rodents and induces striatal increase of neurotrophic factors. Journal of Neurochemistry. 71(6):1998;2439-2446.
70. Dajas-Bailador F.A., Lima P.A., Wonnacott S. The alpha 7 nicotinic acetylcholine receptor subtype mediates ncotine protection against MNDA excitotoxicity in primary hippocampal cultures through Ca2+ dependent mechanism. Neuropharmacology. 39:2000;2799-2807.
71. Levin E.D., Simon B.B. Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacology (Berl). 138(3-4):1998;217-230.
72. Arendash G.W., Sanberg P.R., Sengstock G.J. Nicotine enhances the learning and memory of old rats. Pharmacology Biochemistry & Behavior. 52(3):1995;517-527.
73. Arendash G.W., Sengstock G.J., Sanberg P.R., Kem W.R. Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21. Brain Research. 674:1995;252-259.
74. Socci D., Sanberg P.R., Arendash G.W. Nicotine enhances morris water maze performance of young and aged rats. Neurobiology of Aging. 16(5):1995;1-4.
75. Brook M., Grimshaw J.J. Vitamin C concentration of plasma and leukocytes as related to smoking habit, age, and sex of humans. American Journal Clinical Nutrition. 21(11):1968;1254-1258.
76. Keith M.O., Pelletier O. The effect of nicotine on ascorbic acid retention by guinea pigs. Can Journal of Physiology and Pharmacology. 51(12):1973;879-884.
77. Pelletier O. Smoking and vitamin C levels in humans. American Journal of Clinical Nutrition. 21(11):1968;1259-1267.
78. Pelletier O. Vitamin C status of cigarette smokers and nonsmokers. American Journal of Clinical Nutrition. 23(5):1970;520-524.